Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics

How to Read a Friedreich Ataxia Genetic Test Report

At a Glance

A Friedreich ataxia genetic test report usually shows GAA repeat lengths in both copies of the FXN gene. Two expanded alleles usually confirm the diagnosis, while one may indicate carrier status; the shorter expansion helps estimate risk but cannot predict one person’s future exactly.

When you look at a Friedreich ataxia genetic test report, the most important numbers you will see often correspond to your two copies (or alleles) of the FXN gene—one inherited from each parent [1]. These numbers measure the length of a repeating sequence of DNA called a GAA repeat.

Many labs label the shorter repeat as GAA1 and the longer one as GAA2, but naming conventions can vary, so always check how your specific laboratory defines them [1]. Doctors pay the most attention to the number for your shorter expanded allele (usually called GAA1). This is because the shorter expansion is less damaging to the gene’s ability to produce frataxin—the essential protein that is reduced in this condition [2]. Because it produces more frataxin than the longer allele, the shorter expansion is the primary genetic predictor of when symptoms might start [3].

Understanding Your GAA Repeat Numbers

Friedreich ataxia is caused by an abnormally long GAA section within the FXN gene [4]. In a typical report, your results will fall into categories based on the number of repeats. While exact cutoffs vary slightly among testing laboratories [5], they generally follow this pattern:

  • Normal (usually 5 to 33 repeats): This does not cause the disease.
  • Intermediate or Mutable Normal (usually 34 to 65 repeats): This does not cause symptoms, but the repeat could expand in future generations [6]. If you have this result, a genetic counselor can help explain what it means for family planning.
  • Pathogenic or Expanded (66 or more repeats): This length can cause disease [4]. Commonly, these disease-causing expansions range from 600 to 1,200 repeats [4].

What Your Result May Mean

Friedreich ataxia is an autosomal recessive condition, meaning it typically requires a pathogenic change in both copies of the FXN gene to cause symptoms.

  • Two Expanded Alleles: This is the most common cause of Friedreich ataxia and usually confirms the diagnosis [1].
  • One Expanded Allele: This usually indicates you are a “carrier” who will not develop the disease. However, if you have symptoms of Friedreich ataxia, your doctor may order additional testing to look for a different kind of mutation—like a deletion (missing DNA) or a point mutation (a single letter change in the DNA)—on the other copy of the gene [7][8].
  • No Expanded Alleles: This usually means you do not have Friedreich ataxia, but if symptoms strongly suggest it, further testing might be needed because standard repeat testing doesn’t look for other rare FXN mutations.

What the Repeat Number Can—and Cannot—Tell You

The length of your shorter expanded allele can provide a statistical baseline, but it is not a perfect predictor for your individual future [9].

  • Age of Onset: At a population level, a longer shorter-allele expansion is strongly associated with an earlier age of symptom onset [3]. For example, one large study found that for every additional 100 repeats on the shorter allele, symptoms began about 2.3 years earlier on average [3]. Interestingly, this specific age-of-onset relationship seems to level off once the repeat number reaches about 700 [9].
  • Other Complications: Longer repeat lengths have been associated in studies with lower frataxin levels and an increased likelihood of developing heart muscle disease (cardiomyopathy) and spine curvature (scoliosis) [2][9]. However, these are group-level trends. You must follow routine clinical monitoring guidelines for these complications regardless of your repeat size. A shorter repeat does not mean you can skip heart or spine checkups.
  • Variation Between People: Even among siblings who share very similar repeat numbers, the age when symptoms start and the specific complications they develop can vary [10].
  • Measurement Precision: Genetic tests cannot always count massive repeats with exact precision. Reports for very large expansions might include an estimated margin of error (for instance, ±50 repeats, though this depends entirely on the laboratory’s specific method) [6].
  • Other Genetic Factors: Occasionally, specialized testing reveals uncommon variations, like non-GAA “interruptions” within the repeat sequence, which can sometimes result in milder symptoms than the repeat number alone would suggest [11].

Your doctor will use your genetic test alongside your physical symptoms and other medical evaluations to build a personalized care plan.

Common questions in this guide

What do GAA1 and GAA2 mean on a Friedreich ataxia test report?
GAA1 and GAA2 usually refer to the two FXN gene copies, with one number for each allele. Laboratories may label the shorter and longer repeats differently, so check the report’s definitions; the shorter expanded allele is usually the most important number for estimating age of onset.
What GAA repeat count is considered normal or expanded?
Labs commonly classify about 5–33 repeats as normal, 34–65 as intermediate or mutable normal, and 66 or more as expanded or pathogenic. Cutoffs can vary by laboratory, and disease-causing expansions are often much larger, around 600–1,200 repeats.
Does having one expanded FXN allele mean I have Friedreich ataxia?
Usually, one expanded allele means you are a carrier and will not develop Friedreich ataxia from that result alone. If you have symptoms, your doctor may order testing for a deletion or point mutation in the other FXN copy, because a standard repeat test may not detect those changes.
Can two expanded alleles confirm Friedreich ataxia?
Two expanded FXN alleles usually confirm the genetic cause of Friedreich ataxia, but your doctor will interpret the result alongside your symptoms and other medical evaluations. The report should be reviewed with a clinician or genetic counselor who can explain what it means for your care and family.
Can my GAA repeat number predict when my symptoms will start?
The number of repeats on the shorter expanded allele can provide a statistical estimate: a longer expansion is associated with earlier symptom onset in groups of people. It cannot predict the exact age of onset or complications for one person, and siblings with similar repeat numbers can differ.
Can a negative Friedreich ataxia repeat test rule out the condition?
No expanded alleles usually make Friedreich ataxia unlikely, but standard repeat testing may miss rare FXN deletions or point mutations. If symptoms strongly suggest the condition, your doctor may recommend additional testing.
Do I still need heart and spine monitoring if my repeat number is shorter?
Yes. Repeat length does not eliminate the need for routine monitoring, because cardiomyopathy and scoliosis can occur and individual outcomes vary. Ask your care team what heart, spine, and general health checks are appropriate for you.

Get notified when new evidence is published on Friedreich ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.

    Peverill RE, Donelan L, Corben LA, Delatycki MB

    PloS one 2018; (13(12)):e0209410 doi:10.1371/journal.pone.0209410.

    PMID: 30596685
  2. 2

    Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).

    Reetz K, Dogan I, Hohenfeld C, et al.

    Neurology 2018; (91(10)):e917-e930 doi:10.1212/WNL.0000000000006121.

    PMID: 30097477
  3. 3

    Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.

    Reetz K, Dogan I, Costa AS, et al.

    The Lancet. Neurology 2015; (14(2)):174-82.

    PMID: 25566998
  4. 4

    Sequencing through hyperexpanded Friedreich's ataxia-GAA repeats by nanopore technology: implications in genotype-phenotype correlation.

    Uppili B, Sharma P, Ahmad I, et al.

    Brain communications 2023; (5(2)):fcad020 doi:10.1093/braincomms/fcad020.

    PMID: 37006329
  5. 5

    Unlocking Sulforaphane's Potential in Friedreich Ataxia: Further Evidence from Preclinical Investigations Using Induced Pluripotent Stem Cell-Derived Sensory Neurons.

    Yang W, Thompson B, Miellet S, et al.

    Antioxidants & redox signaling 2026; (45(13-15)):561-580 doi:10.1177/15230864261470377.

    PMID: 42473835
  6. 6

    A Comprehensive Triple-Repeat Primed PCR and a Long-Range PCR Agarose-Based Assay for Improved Genotyping of Guanine-Adenine-Adenine Repeats in Friedreich Ataxia.

    Jama M, Margraf RL, Yu P, et al.

    The Journal of molecular diagnostics : JMD 2022; (24(8)):915-923 doi:10.1016/j.jmoldx.2022.04.008.

    PMID: 35595154
  7. 7

    Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling.

    Hoffman-Zacharska D, Mazurczak T, Zajkowski T, et al.

    Journal of applied genetics 2016; (57(3)):349-55 doi:10.1007/s13353-015-0331-4.

    PMID: 26906906
  8. 8

    Pitfalls in molecular diagnosis of Friedreich ataxia.

    Barcia G, Rachid M, Magen M, et al.

    European journal of medical genetics 2018; (61(8)):455-458 doi:10.1016/j.ejmg.2018.03.004.

    PMID: 29530802
  9. 9

    Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia.

    Rodden LN, Rummey C, Dong YN, Lynch DR

    Neurology. Genetics 2022; (8(3)):e683 doi:10.1212/NXG.0000000000000683.

    PMID: 35620135
  10. 10

    Genetic and Phenotypic Variability in Siblings With Friedreich Ataxia.

    Eshaghi K, Rao PH, Shen MM, Lynch DR

    Neurology. Genetics 2025; (11(1)):e200234 doi:10.1212/NXG.0000000000200234.

    PMID: 40880907
  11. 11

    Interruptions of the FXN GAA Repeat Tract Delay the Age at Onset of Friedreich's Ataxia in a Location Dependent Manner.

    Nethisinghe S, Kesavan M, Ging H, et al.

    International journal of molecular sciences 2021; (22(14)) doi:10.3390/ijms22147507.

    PMID: 34299126

This page is for informational purposes only and does not constitute medical advice or a diagnosis. Your doctor or genetic counselor should interpret your Friedreich ataxia report and recommend monitoring for your situation.